BERETTA SIMONE

Roberti, R., Politi, C., Anzellotti, F., Belcastro, V., Beretta, S., Boero, G., et al. (2026). Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar Efficacy. NEUROLOGY AND THERAPY, 15(1), 213-235 [10.1007/s40120-025-00860-5]. Dettaglio

Giussani, G., Bianchi, E., Carlando, E., Difrancesco, J., Tabaee Damavandi, P., Pasini, F., et al. (2025). Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single-blind, non-inferiority trial (STANDLOW). EPILEPSIA OPEN, 10(2 (April 2025)), 643-653 [10.1002/epi4.70016]. Dettaglio

Beretta, S., Tettamanti, M., Mariani, J., Diamanti, S., Valente, A., Cuomo, O., et al. (2025). Multicenter Translational Trial of Remote Ischemic Conditioning in Acute Ischemic Stroke (TRICS BASIC). STROKE, 52(12), 3342-3351 [10.1161/STROKEAHA.125.051532]. Dettaglio

Sala, G., Cuffaro, L., Pozzi, F., Andreoni, S., Bazzini, C., Conti, E., et al. (2025). Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network). FRONTIERS IN AGING NEUROSCIENCE, 17 [10.3389/fnagi.2025.1581892]. Dettaglio

Lattanzi, S., Dono, F., D'Orsi, G., D'Aniello, A., Panebianco, M., Bonanni, P., et al. (2025). Effectiveness and safety of adjunctive cenobamate in people with focal-onset epilepsy: Interim results after 24-week observational period from the BLESS study. EPILEPSIA, 66(7), 2239-2252 [10.1111/epi.18357]. Dettaglio